Malaria in the WHO EurOpEan region

Transcription

1 Malaria in the WHO EurOpEan region This information leaflet contains six sections and is intended for a generic and public health audience: 1.Malaria is present in certain areas of Europe. What are the risks in European countries? 2.Malaria is transmitted by Anopheles mosquitoes. How is the disease transmitted? What are the risk factors? 3.Disease characteristics of malaria. What are the symptoms and how can it be treated? 4.Malaria can be prevented. What measures can be taken to protect yourself? 5.WHO response. How is WHO responding and what support could you get? 6.More information is available. Where can you find more information and guidance on effective prevention and control activities? Key messages Malaria is a life-threatening disease caused by parasites (genus: Plasmodium) that are transmitted to people through the bites of infected mosquitoes (genus: Anopheles). In 2012, malaria caused an estimated deaths, mostly among African children. In the WHO European Region, malaria elimination remains on track: only 37 cases of locally acquired malaria were reported in 2013 (in Greece, Tajikistan and Turkey). At present, imported malaria remains a significant medical and health issue in many European countries. Non-immune travellers from malaria-free areas are very vulnerable to the disease when they become infected. Malaria is preventable and curable. The WHO Regional Office for Europe continues to support countries in their efforts to reach the agreed targets and goals and to provide technical assistance in the certification of malaria elimination whenever possible. CDC/James Gathany

2 1. Malaria is present in certain areas of Europe Most malaria cases and deaths occur in sub-saharan Africa; however, Asia, Latin America and, to a lesser extent, the Middle East and parts of Europe, are also affected. In 2013, 97 countries and territories had ongoing malaria transmission. Since 2000, a tremendous expansion in the financing and coverage of malaria-control programmes has led to a widescale reduction in malaria cases and deaths. History of malaria in Europe The perception that Europe is free from malaria has changed rapidly and, since the early 1980s, the number of countries affected by local malaria transmission has increased from 3 to 10. At the beginning of the 1990s, the residual reservoir of malaria infection, aggravated by political and socio-economic situations, mass population migration, extensive development projects, and almost discontinued activities on malaria prevention and control, constituted conditions favourable for malaria transmission. As a result, large-scale epidemics broke out in central Asia and the Transcaucasian countries; in 1995, a total of malaria cases were officially reported in the Region (Fig.1). In those years, Azerbaijan, Tajikistan and Turkey suffered explosive and extensive epidemics, while Armenia, Kyrgyzstan and Turkmenistan faced outbreaks on a smaller scale. Fig 1. reported number of cases of malaria in all countries of the WHO European region, Source: WHO centralized information system for infectious diseases (CISID). The WHO Regional Office for Europe committed itself to an intensive response to the burden of malaria and, by 1999, had developed the Roll Back Malaria strategy in affected countries of the Region. Between 1995 and 2005, the reported number of locally acquired cases of malaria declined significantly as a result of large-scale anti-malaria containment activities. Almost all cases occurring in European Union countries were imported from endemic areas.

3 The WHO European Region is close to attaining the goal of eliminating malaria from the Region by 2015, as set out in the Tashkent Declaration The Move from Malaria Control to Elimination in the WHO European Region (2005), which was endorsed by nine malaria-affected countries. In areas of the Region with relatively low transmission, the intensive application of vector-control measures, combined with sufficient disease management and surveillance activities of adequate quality, have brought the transmission of malaria almost completely under control (Fig. 2). Fig. 2. Classification of countries by stage of malaria elimination as of December Of the nine countries with ongoing transmission in 2000, three have been certified free of malaria (Armenia in 2011, Turkmenistan in 2010 and Kazakhstan in 2012) and two (Kyrgyzstan and Uzbekistan), having reported zero indigenous cases for the past three years or more, are currently in the prevention-of-reintroduction phase. Azerbaijan interrupted transmission of malaria in The remaining countries (Tajikistan and Turkey) have each achieved a reduction in cases of more than 75%. The transmission of autochthonous P. falciparum malaria was interrupted in Tajikistan in 2009, thus eliminating this type of malaria from the entire Region. All locally acquired cases are due to P. vivax. Greece, which had remained malaria free between 1974 and 2010, reported 3 locally acquired P. vivax cases in 2010, 40 in 2011 and 20 in 2012; these cases originated initially from migrant workers. In 2013, 3 locally acquired P. vivax cases were detected. The experience of Greece highlights the continual threat of reintroduction and the need for continued vigilance to ensure that any resurgence can be rapidly contained. At present, imported malaria is a significant medical and health issue in many European countries where the disease has been successfully eliminated. Around 5000 imported malaria cases are reported annually in the Region but the magnitude of the problem is thought to be much greater than the statistics indicate and cannot be reliably assessed on the basis of the official data available.

4 2. Malaria is transmitted by mosquitoes Malaria is caused by Plasmodium parasites, which are spread to people through the bites of infected female Anopheles mosquitoes. At present, there are 19 principal and secondary Anopheles species in the WHO European Region. All of the important vector species bite at night. Anopheles mosquitoes breed in water and each species has its own breeding preference; for example, some prefer shallow collections of fresh water, such as in puddles, rice fields, and hoof prints. Transmission is more intense in places where the mosquito lifespan is longer (so that the parasite has time to complete its development inside the mosquito) and where it prefers to bite humans rather than animals. For example, the long lifespan and strong human-biting habit of the African vector species are the main reasons why more than 90% of the world's malaria deaths occur in Africa. The intensity of transmission depends on factors related to the parasite, the vector, the human host and the environment. There are four parasite species that cause malaria in humans: Plasmodium falciparum; Plasmodium vivax; Plasmodium malariae; and Plasmodium ovale. In Europe, Plasmodium vivax is the most common and the only malaria parasite species present in local transmission but infected travellers or migrants can also carry the other forms. Plasmodium falciparum is the most deadly species. Transmission also depends on climatic conditions that may affect the number and survival of mosquitoes, such as rainfall patterns, temperature and humidity. In many places, transmission is seasonal, peaking during and just after the rainy season. WHO

5 3. Disease characteristics of malaria Albert Bonniers Forlag Malaria is an acute illness, causing fever and influenza-like symptoms. In a non-immune individual, symptoms appear between 7 and 15 days after the infective mosquito bite but longer incubation periods are possible. The first symptoms fever, headache, chills and vomiting may be mild and difficult to recognize as malaria. If not treated within 24 hours, P. falciparum malaria can progress to severe illness and death. In malaria-endemic areas, people may develop partial immunity, allowing asymptomatic infections to occur. Clinical relapses of malaria caused by P. vivax or P. ovale may occur weeks to months after the first infection, even if the patient has left the malarious area. These new episodes arise from dormant liver forms known as hypnozoites (absent in P. falciparum and P. malariae); special treatment targeted at these liver stages is required for a complete cure. The early diagnosis and treatment of malaria reduces the duration of the disease and prevents death. It also contributes to reducing malaria transmission. The best available treatment, particularly for P. falciparum malaria, is artemisinin-based combination therapy (ACT). Resistance to antimalarial medicines is a continuing problem. While many factors likely contribute to the emergence and spread of resistance, the use of oral artemisinins alone, as monotherapy, is thought to be an important driver. Treatment of malaria with an oral artemisinin-based monotherapy results in the rapid disappearance of symptoms, which may cause patients to discontinue treatment prematurely. This would result in incomplete treatment and such patients would still have persistent parasites in their blood. Without a second drug, given as part of a combination (as provided by ACT), these resistant parasites survive and can be passed on to a mosquito and then to another person. 4. Malaria can be prevented There are currently no licensed vaccines against malaria or any other human parasite. Prevention is based on two complementary methods: vector control to reduce malaria transmission, and chemoprophylaxis. For individuals, personal protection against mosquito bites represents the first line of defence in malaria prevention. In areas where malaria is endemic, insecticide-treated mosquito nets can offer individual protection at night when malaria transmission is most likely to occur. WHO recommends coverage for all persons at risk, and in most settings. This should be complemented with other methods of protection against mosquito bites, including clothes that cover most of the body and the use of insect repellent on exposed skin. Repellents can be applied to exposed skin and clothing in strict accordance with product label instructions. Antimalarial medicines can also be used to prevent malaria. Travellers to malaria-endemic countries can protect themselves through chemoprophylaxis, which suppresses the blood stage of malaria infections, thereby preventing the disease. The choice of drugs depends on the travel destination, the duration of potential exposure to vectors, the parasite resistance pattern, the level and seasonality of transmission, the age the person and, in the case of a woman, whether she is pregnant.

6 5. WHO response The WHO Global Malaria Programme is responsible for charting the course for malaria control and elimination by: setting and communicating evidence-based norms, standards, policies, technical strategies and guidelines, and promoting their adoption; keeping an independent score of global progress; developing approaches to capacity building, systems strengthening, and surveillance; identifying threats to malaria control and elimination, as well as new areas for action. The European Centre for Disease Prevention and Control, the European Commission, the European Mosquito Control Association and WHO are working together to raise awareness of the problem and provide advice to countries on surveillance and control activities. Tracking progress is a major challenge in malaria control. Malaria surveillance systems detect only around 14% of the estimated global number of cases. Stronger malaria surveillance systems are urgently needed to enable a timely and effective malaria response in endemic regions, prevent outbreaks and resurgences, track progress and hold governments and the global malaria community accountable. In April 2012, the WHO Director-General launched global surveillance manuals on malaria control and elimination and urged endemic countries to strengthen their malaria surveillance systems. This was embedded in a new WHO initiative, T3: Test. Treat. Track, to scale up diagnostic testing, treatment and surveillance of malaria. WHO also recommends the routine monitoring of antimalarial drug resistance and supports countries in strengthening their efforts in this important area. Box 1. What is a vector-borne disease? Vector-borne diseases are illnesses caused by pathogens in human populations. These diseases are spread by vectors: living organisms that can transmit pathogens between humans or from animals to humans. Many vectors are bloodsucking insects, which ingest pathogens during a blood meal from infected hosts (humans or animals) and transfer them to new hosts during subsequent blood meals. Mosquitoes are the best known disease vectors. Others include certain species of ticks, flies, sandflies, and fleas. WHO

7 6. More information is available WHO documents Disease surveillance for malaria elimination: an operational manual. Geneva: World Health Organization; 2012 (http://www.who.int/malaria/publications/atoz/ /en/). Ejov M. Scaling up the response to malaria in the WHO European Region: progress towards curbing an epidemic Copenhagen: World Health Organization; 2005 (http://www.euro.who.int/en/health-topics/communicable-diseases/vector-borne-and-parasitic-diseases/publications/ pre-2009/scaling-up-the-response-to-malaria-in-the-who-european-region-progress-towards-curbing-an-epidemic ). Greater effort needed to eliminate malaria from Europe by 2015[website]. Copenhagen: World Health Organization; 2013 (http://www.euro.who.int/en/health-topics/health-determinants/millenium-development-goals/news/news/2013/04/ greater-effort-needed-to-eliminate-malaria-from-europe-by-2015). International travel and health [website]. Geneva: World Health Organization; 2014 (http://www.who.int/ith/en/). Regional strategy: from malaria control to elimination in the WHO European Region Copenhagen: WHO Regional Office for Europe; 2006 (http://www.euro.who.int/en/health-topics/communicable-diseases/vector-borne-and-parasitic-diseases/publications/ pre-2009/regional-strategy-from-malaria-control-to-elimination-in-the-who-european-region ). The Tashkent Declaration The move from malaria control to elimination in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2005 (http://www.euro.who.int/en/health-topics/communicable-diseases/vector-borne-and-parasitic-diseases/publications/ pre-2009/tashkent-declaration-the-move-from-malaria-control-to-elimination). WHO European Region aims to wipe out malaria in 4 years: Roll Back Malaria partners target strongholds of the disease [website]. Copenhagen: World Health Organization; 2011 (http://www.euro.who.int/en/media-centre/sections/latest-press-releases/who-european-region-aims-to-wipe-outmalaria-in-4-years-roll-back-malaria-partners-target-strongholds-of-the-disease ). World Malaria Report Geneva: World Health Organization; 2013 (http://www.who.int/malaria/publications/world_malaria_report_2013/en/). External resources Askling H et al. Management of imported malaria in Europe. Malaria Journal. 2012;11:328 (http://www.malariajournal.com/content/pdf/ pdf). Factsheet for health professionals malaria [website]. Stockholm: European Centre for Disease Prevention and Control; 2014 (http://www.ecdc.europa.eu/en/healthtopics/malaria/factsheet-health-professionals/pages/factsheet_health_ professionals.aspx).

8 Malaria in the WHO EurOpEan region WHO Regional Office for Europe UN City, Marmorvej 51 DK-2100 Copenhagen Ø, Denmark

Fact sheet Key facts is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected mosquitoes. In 2012, malaria caused an estimated 18 000 deaths in the

Frequently asked questions for malaria 1. What is malaria? Malaria is an infectious disease caused by a parasite that is transmitted through bite of an infected mosquito at night. There are two main types

Page 1 EPIDEMIOLOGICAL SURVEILLANCE REPORT Malaria in Greece, 2015, up to 26/08/2015 Introduction Malaria is a parasitic infection, transmitted through the bite of the infected female Anopheles mosquito.

Brief on Malaria Malaria is a deadly mosquito-borne disease afflicting as many as 500 million people in 106 countries in Africa, Asia and Latin America. It is estimated that, annually, the disease causes

James Paget University Hospitals NHS Foundation Trust Malaria Patient Information What is malaria? Malaria is a serious and potentially life threatening illness caused by infection with the protozoan parasite,

Page 1 EPIDEMIOLOGICAL SURVEILLANCE REPORT Malaria in Greece, 2016, up to 03/08/2016 Introduction Malaria is a parasitic infection, transmitted through the bite of the infected female Anopheles mosquito.

West Nile virus in the WHO european region This information leaflet contains six sections and is intended for a generic and public health audience: 1. WNv is found in europe. What are the risks in European

Lyme borreliosis in europe This information leaflet contains five sections and is intended for a generic and public health audience: 1.Lb is found in certain areas of europe. What are the risks in European

Malaria Why should I worry about malaria? Globally, malaria is one of the six major causes of deaths from communicable diseases. 90% of world s approximately 600 000 annual malaria deaths occur in Africa.

Dengue in the WHO european region This information leaflet is intended to guide public health authorities in protecting their populations from the health risks of dengue. The following sections will answer

! " #$%$&'$() *#$%(%++, MALARIA MALARIA IN MAURITIUS There were no declared cases of malaria in Mauritius during the period of French colonization 1715-1810 despite important ship movements with Madagascar,

Summary and Key Points The World Malaria Report 2011 summarizes information received from 106 malaria-endemic countries and other sources and updates the analyses presented in the 2010 report. It highlights

Scaling up diagnostic testing, treatment and surveillance for malaria World Health Organization 2012 All rights reserved. Publications of the World Health Organization are available on the WHO web site

Executive Summary The Global Malaria Action Plan The Roll Back Malaria (RBM) Partnership has developed the Global Malaria Action Plan (GMAP) first and foremost to support countries. The GMAP provides a

Update on autochthonous Plasmodium vivax malaria in Greece 11 October 2011 Main conclusions and recommendations Greece has reported thirty-six cases of Plasmodium vivax infection in 2011 to date, 20 of

MALARIA INTRODUCTION CAUSES 1-3 MILLION DEATHS A YEAR ( MAINLY CHILDREN ). IT REMAINS A MAJOR BURDEN IN TROPICAL COUNTRIES. MALARIA MEANS MAL AIR NEAR SWAMPS. PARASITE GENUS : PLASMODIUM (SPOROZOA) SPECIES

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

Yellow fever Introduction Yellow fever is endemic in many countries in Africa, Central and South America with 90% of annual cases worldwide reported from sub-saharan Africa. The World Health Organization

Malaria Fact-file Malaria Fact - File malaria should not be viewed as a given part of life rather it is a preventable and curable disease that can be eliminated. Malaria Facts Many of those who test positive

Monitoring and evaluating progress in malaria control in the African Region Introduction * Dr M Lama Malaria is one of the leading causes of disease, suffering and deaths in the world, with the highest

This is the written version of our Hot Topic video presentation available at: MayoMedicalLaboratories.com/hot-topics Welcome to Mayo Medical Laboratories Hot Topics. These presentations provide short discussion

REPORT BY THE COMPTROLLER AND AUDITOR GENERAL HC 534 SESSION 2013-14 3 JULY 2013 Department for International Development Malaria 4 Key facts Malaria Key facts 17 countries in which the Department funds

Plasmodium vivax Control & Elimination: Development of Global Strategy and Investment Case September 2012 1. Background While Plasmodium falciparum is responsible for the vast majority of cases and deaths

FREQUENTLY ASKED QUESTIONS: MALARIA ARE THERE DIFFERENT KINDS OF MALARIA? Yes, there are five types of human malaria namely falciparum, vivax, ovale, malariae and knowlesi. All malarias are found in the

Key points The World malaria report 2015 assesses global malaria disease trends and changes in the coverage and financing of malaria control programmes between 2000 and 2015. It also summarizes progress

RTS,S (Mosquirix ) Frequently Asked Questions (FAQs) 1. What is RTS,S? RTS,S is the first malaria vaccine candidate to receive a positive scientific opinion from the European Medicines Agency (EMA), whose

Zika Virus Frequently Asked Questions for the General Public Version 1.12: 25/7/2016 What is Zika? Zika is a viral infection that usually causes a mild illness that typically lasts between 2 and 7 days.

Malaria prevention advice for travellers Please read this information carefully it won t take you very long. What is malaria? Malaria is a parasitic infection spread to humans by the bite of an infected

Zika Virus Frequently Asked Questions: Zika Virus and Pregnancy Version 1.12: 25/7/2016 What is Zika? Zika is a viral infection that usually causes a mild illness that typically lasts between 2 and 7 days.

CHAPTER 7 SUMMARY Anaemia is an inevitable consequence of Plasmodium falciparum malaria infection, especially in areas of high malaria transmission. In these settings, the group at highrisk for malaria-associated

The third pea in the pod Perry JJ van Genderen, MD, PhD Institute for Tropical Diseases, Harbour Hospital, Rotterdam, The Netherlands IMPORTED MALARIA IN THE NETHERLANDS Number of infections 800 imported

Dengue Fever: A Bad Case of Flu While in the Amazon jungle of Peru during January of 2005, an infectious disease physician from the United States told me and my students that dengue fever is not in the

Yes No If yes, was Eosinophilia present? Yes No Results pending If yes, was further evaluation done? Yes No ( one) Yes No If why not? Done Results Pending Not done Negative Positive; treated: yes no Indeterminate

WHO/CDS/CSR/ISR/2000.1 WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases World Health Organization Department of Communicable Disease Surveillance and Response This document has been

Malaria IPC GUIDE What is Malaria? What is Malaria? What is Malaria? Malaria is a life-threatening parasitic disease How is Malaria Caused? Malaria is caused by plasmodium falciparum parasite trasnsmited

Summary of Key Points WHO Position Paper on Vaccination Against Dengue July 2016 Background Number of dengue cases reported annually to WHO has increased from 0.4 to 1.3 million between 1996-2005, reaching

Malaria prevention and treatment INTEGRATED MANAGEMENT OF PREGNANCY AND CHILDBIRTH (IMPAC) Standards for Maternal and Neonatal Care The standard In malarious areas, all pregnant women should sleep under

Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/focus-on-global-medicine/toward-malaria-prevention-and-control/4042/

Chikungunya in the WhO EurOpEan region This information leaflet contains six sections and is intended for a generic and public health audience: 1.Chikungunya appeared in Europe in 2007. What are the risks

Medication Guide LARIAM (LAH-ree-am) (mefloquine hydrochloride) Tablets to Prevent Malaria This Medication Guide is intended only for travelers who are taking Lariam to prevent malaria. The information

Zika Virus Zika fever is caused by the Zika virus (ZIKV), an arthropod-borne virus (arbovirus). The Zika virus is a member of the Alphavirus genus in the family Togaviridae. It is related to dengue, yellow

IS RELIGIOUS AFFILIATION INFLUENCING PREVENTION AND TREATMENT OF MALARIA AMONG CHILDREN IN UGANDA? AUTHORS Ndugga Patricia AFFILIATION Department of Population Studies, Makerere University, Uganda EXTENDED

Guidelines for the treatment of malaria Guidelines for the treatment of malaria WHO Library Cataloguing-in-Publication Data Guidelines for the treatment of malaria/world Health Organization. Running title:

Dedicated to Providing the Ultimate Health & Hygiene Protection for Travellers Mosquito Borne Disease Mosquitoes are one of the world s deadliest insects helping to spread disease. Worldwide it is estimated

Global Malaria Programme The use of DDT in malaria vector control WHO position statement World Health Organization, 2011 All rights reserved. The designations employed and the presentation of the material

Fact sheet 1 - advice for travellers If you travel from the UK to tropical and sub-tropical regions of the world you should follow the ABCDE approach to protect yourself against malaria. Awareness of the

COMMITTEE: World Health Organization Malaria, Tuberculosis, and Other Infectious Diseases READ TO DISCOVER: 1. What are the effects of Malaria, Tuberculosis, and other Infectious diseases? 2. Where are